DiaMedica Inc.
8Patents
7Active
8Granted
49Portfolio score
Filing activity: Jan 27, 2003 → Nov 3, 2023 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7622447B2 | Use of glutathione synthesis stimulating compounds in reducing insulin resistance | Human Necessities | 17 | Expired |
| US9364521B2 | Human tissue kallikrein 1 glycosylation isoforms | Chemistry; Metallurgy | 4 | Active |
| US9616015B2 | Formulations of human tissue kallikrein-1 for parenteral delivery and related methods | Human Necessities | 2 | Active |
| US9839678B2 | Human tissue kallikrein 1 glycosylation isoforms | Chemistry; Metallurgy | 2 | Active |
| US8501695B2 | Tissue kallikrein for the treatment of diseases associated with amyloid protein | Human Necessities | 2 | Active |
| US8673964B2 | Use of drug combinations for treating insulin resistance | Human Necessities | 1 | Active |
| US11857608B2 | Dosage forms of tissue kallikrein 1 | Chemistry; Metallurgy | 1 | Active |
| US12329805B2 | Dosage forms of tissue kallikrein 1 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.